Description: The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
Home Page: us.spdrs.com/en/product/fund.seam?ticker=XBI
XBI Technical AnalysisExchange: NYSE ARCA
Country: US
Currency: US Dollar ($)
Category: Health
Asset Allocation | |||
---|---|---|---|
Asset Class | Long % | Short % | Net Assets |
Stock US | 97.32 | 0.00 | 97.32 |
Stock non-US | 2.63 | 0.00 | 2.63 |
Cash | 0.05 | 0.00 | 0.05 |
Sector Weights | ||
---|---|---|
Sector | Equity % | Relative to Category |
Healthcare | 100.00 | 99.57 |
World Regions | ||
---|---|---|
Region | Equity % | Relative to Category |
North America | 97.37 | 92.60 |
Europe Developed | 2.35 | 4.28 |
United Kingdom | 0.28 | 1.65 |
Japan | 0.00 | 0.54 |
Australasia | 0.00 | 0.11 |
Asia Emerging | 0.00 | 0.82 |
Africa/Middle East | 0.00 | 0.02 |